US 7214690
Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
granted A61PA61P13/08A61P15/08
Quick answer
US patent 7214690 (Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods) held by Ligand Pharmaceuticals Incorporated expires Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue May 08 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 58
- CPC classes
- A61P, A61P13/08, A61P15/08, A61P15/10, A61P17/00